URBN
64
-2
IPG
47
-3
DFS
70
-4
AIV
62
-2
LLY
45
-6
GILD
60
-3
EXR
55
-5
HP
41
-4
TGNA
59
-5
AMG
38
-3
DVN
25
-3
OXY
49
-3
PPG
60
-4
CHD
50
2
AN
52
-2
GM
68
-3
MLM
60
-4
SEE
52
-3
NTAP
64
-2
HAS
33
-2
URBN
64
-2
IPG
47
-3
DFS
70
-4
AIV
62
-2
LLY
45
-6
GILD
60
-3
EXR
55
-5
HP
41
-4
TGNA
59
-5
AMG
38
-3
DVN
25
-3
OXY
49
-3
PPG
60
-4
CHD
50
2
AN
52
-2
GM
68
-3
MLM
60
-4
SEE
52
-3
NTAP
64
-2
HAS
33
-2
Financhill
Back

iShares Enhanced ST Bond Active ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
39

CSHP
iShares Enhanced ST Bond Active ETF

Last Price:
100.43
Seasonality Move:
--
Sell
47

APLS
Apellis Pharmaceuticals

Last Price:
29.00
Seasonality Move:
20.78%
Sell
39
iShares Enhanced ST Bond Active ETF (CSHP) is a Sell

Is iShares Enhanced ST Bond Active ETF a Buy, Sell or Hold?

  • The current iShares Enhanced ST Bond Active ETF [CSHP] share price is $100.43. The Score for CSHP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CSHP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSHP Stock Price Chart

What is iShares Enhanced ST Bond Active ETF's stock price today?

  • The iShares Enhanced ST Bond Active ETF share price today is $100.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSHP is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $29.26
    The current trend is relatively stagnant and APLS is experiencing slight buying pressure.

CSHP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 55.65 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.3 - 100.46) Buy
Bollinger Bands (100): ( - ) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 52.74 Buy
Chaikin Money Flow: 179519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.95 - 28.71) Buy
Bollinger Bands (100): (29.49 - 39.35) Sell

CSHP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.37 Buy
20-day SMA: 100.4 Buy
50-day SMA: 100.32 Buy
200-day SMA: 0 Buy
8-day EMA: 100.41 Buy
20-day EMA: 100.39 Buy
50-day EMA: 80.11 Buy
200-day EMA: 33.09 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.88 Buy
20-day SMA: 28.02 Buy
50-day SMA: 30.86 Sell
200-day SMA: 43.85 Sell
8-day EMA: 28.92 Buy
20-day EMA: 28.61 Buy
50-day EMA: 30.58 Sell
200-day EMA: 40.41 Sell

iShares Enhanced ST Bond Active ETF Earnings Growth & CSHP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

iShares Enhanced ST Bond Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):